Medicare Enrolled

Dr. Walter Taylor, M.D.

Neurology · Rockwall, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
6701 HERITAGE PKWY, Rockwall, TX 75087
9724128700
In practice since 2005 (20 years)
NPI: 1992709620 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Taylor from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Taylor? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Taylor

Dr. Walter Taylor is a neurology in Rockwall, TX, with 20 years in practice. Based on federal Medicare data, Dr. Taylor performed 16,520 Medicare services across 2,050 unique beneficiaries.

Between the years covered by Open Payments, Dr. Taylor received a total of $5,432 from 51 pharmaceutical and/or device companies across 249 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Taylor is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 5% volume in TX$ $5,432 industry payments

Medicare Practice Summary

Medicare Utilization ↗
16,520
Medicare services
Top 5% in TX for neurology
2,050
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~826 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit12,341$5$30
Office visit, established patient (30-39 min)1,024$86$500
Injection of anesthetic agent and/or steroid into lower back and leg nerve (sciatic nerve)596$174$294
Injection of anesthetic agent and/or steroid into thigh nerve (femoral nerve)596$63$192
Needle measurement of electrical activity in arm or leg muscles, complete study488$72$400
New patient office visit (45-59 min)335$120$1,000
Measurement of brain wave activity with video (veeg), 12-26 hours with intermittent monitoring156$799$7,000
Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional156$156$1,000
Measurement of brain wave activity (eeg), awake and drowsy156$278$1,400
Nerve conduction, 11-12 studies122$187$1,400
Nerve conduction, 13 or more studies105$208$1,600
Injection of anesthetic agent and/or steroid into upper neck and back of head nerve56$79$500
Injection of trigger points, 3 or more muscles52$23$500
Measurement of brain wave activity (eeg), continuous52$199$2,000
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face48$112$680
Complete ultrasound of within the brain blood flow41$162$600
Ultrasound of within the brain blood flow following medication41$168$500
Ultrasound of within the brain blood flow for blood clots41$125$500
Ultrasound of both sides of head and neck blood flow39$118$500
Office visit, established patient (20-29 min)35$65$400
Nerve conduction, 9-10 studies18$162$1,300
Punch biopsy, first skin growth11$96$300
Punch biopsy, each additional skin growth11$45$250
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,432
Total received (2018-2024)
Avg $776/year across 7 years
Top 38% in TX for neurology
51
Companies
249
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,419 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,448
2023
$1,769
2022
$523
2021
$118
2020
$62
2019
$311
2018
$202

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$380
ABBVIE INC.
$375
AbbVie Inc.
$348
SK Life Science, Inc.
$307
PFIZER INC.
$282
ARGENX US, INC.
$246
Merz North America, Inc.
$242
Merz Pharmaceuticals, LLC
$241
Lundbeck LLC
$223
Sumitomo Pharma America, Inc.
$211
Novartis Pharmaceuticals Corporation
$196
Abbott Laboratories
$194
Genentech USA, Inc.
$194
Biogen, Inc.
$173
GENZYME CORPORATION
$164
Neurocrine Biosciences, Inc.
$151
Teva Pharmaceuticals USA, Inc.
$146
MDD US Operations, LLC
$131
ACADIA Pharmaceuticals Inc
$118
Celgene Corporation
$111
Kyowa Kirin, Inc.
$97
Eisai Inc.
$75
Lilly USA, LLC
$60
Amgen Inc.
$50
Otsuka America Pharmaceutical, Inc.
$50
Harmony Biosciences LLC
$42
GE HealthCare
$42
Grifols USA, LLC
$42
GE HEALTHCARE
$39
Myriad Genetic Laboratories, Inc.
$33
Upsher-Smith Laboratories LLC
$33
Biohaven Pharmaceutical Holding Company Ltd.
$31
Alexion Pharmaceuticals, Inc.
$31
HOSPIRA, INC.
$29
Allergan, Inc.
$29
US WorldMeds, LLC
$27
Corium, LLC
$26
Blue Earth Diagnostics Limited
$24
EISAI INC.
$23
Boston Scientific Corporation
$23
Allergan Inc.
$22
IMPEL PHARMACEUTICALS INC.
$20
Medtronic, Inc.
$20
BIOTRONIK NRO, Inc.
$19
Neurelis, Inc.
$19
Nevro Corp.
$18
Ipsen Biopharmaceuticals, Inc
$17
AbbVie, Inc.
$16
IDORSIA PHARMACEUTICALS US INC
$14
EMD Serono, Inc.
$13
Sunovion Pharmaceuticals Inc.
$12
Top 3 companies account for 20.3% of total payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUSTEDO · Adlarity · Aimovig · Austedo XR · BIOTRONIK · BOTOX · BOTOX THERAPEUTIC · Briviact · COMIRNATY · DAYBUE · Duopa · Dysport · EMGALITY · Enspryng · Fycompa · Gamunex-C · Gocovri · INFINITY · INGREZZA · INTELLIS ADAPTIVESTIM · KESIMPTA · Leqembi · Mavenclad · NOURIANZ · NUPLAZID · NURTEC ODT · Nourianz · OCTAGAM IMMUNE GLOBULIN (HUMAN) · Ocrevus · POSLUMA · PROCLAIM · Proclaim Family of SCS IPGs · QULIPTA · QUVIVIQ · REXULTI · Rystiggo · Senza · TOSYMRA SUMATRIPTAN NASAL SPRAY · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · WAKIX · XADAGO · XCOPRI · XEOMIN · Xadago · Xeomin · ZAVZPRET · ZEPOSIA · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $33 per 100 Medicare services performed
Looking for a neurology in Rockwall?
Compare neurologys in the Rockwall area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
126
Per 100K population
107.8
County median income
$124,917
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL ROCKWALL
6.4 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Taylor is a mixed practice specialist, with above-average Medicare volume (top 5% in TX), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Taylor experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Taylor performed 12,341 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Taylor receive payments from pharmaceutical companies?
Yes. Dr. Taylor received a total of $5,432 from 51 companies across 249 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Taylor's costs compare to other neurologys in Rockwall?
Dr. Taylor's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Taylor) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →